Clinical Data Narrows Fiscal Q1 Net Loss as it Preps for PGx Future | GenomeWeb
NEW YORK (GenomeWeb News) — Clinical Data on Tuesday reported that it trimmed its fiscal first-quarter net loss by 12 percent as revenues fell 20 percent and research and development spending fell 17 percent.
 
Total receipts for the three months ended June 30 decreased to $14 million from $17.6 million in the fiscal first quarter of 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: flu susceptibility and Y chromosome variation in mice, deletion tied to epilepsy in dog breed, and more.

Sequencing is enabling the roots of some rare diseases to be determined, the Financial Times reports.

Proove Biosciences had allegedly been paying doctors to perform its opioid risk and other genetic tests, Stat News reports.

A floated budget plan could see non-military discretionary spending in the US — which includes science agency funding — fall, the New York Times reports.